Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 44095/0025.
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
piperacillin/tazobactam
1. What Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is and what it is used for
2. What you need to know before you use Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
3. How to use Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
4. Possible side effects
5. How to store Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
6. Contents of the pack and other information
Piperacillin belongs to the group of medicines known as “broad-spectrum penicillin antibiotics”. It can kill many kinds of bacteria. Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion can prevent some resistant bacteria from surviving the effects of piperacillin. This means that when piperacillin and tazobactam are given together, more types of bacteria are killed.
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is used in adults and adolescents aged above 12 years to treat bacterial infections, such as those affecting the lower respiratory tract (lungs), urinary tract (kidneys and bladder), abdomen, skin or blood. Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion may be used to treat bacterial infections in patients with low white blood cell counts (reduced resistance to infections).
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is used in children aged 2-12 years to treat infections of the abdomen such as appendicitis, peritonitis (infection of the fluid and lining of the abdominal organs), and gallbladder (biliary) infections. Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion may be used to treat bacterial infections in patients with low white blood cell counts (reduced resistance to infections).
In certain serious infections, your doctor may consider using Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion in combination with other antibiotics.
Talk to your doctor, pharmacist or nurse before using Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion
Piperacillin / tazobactam is not recommended for use in children below the age of 2 years due to insufficient data on safety and effectiveness.
Please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription. Some medicines may interact with piperacillin and tazobactam.
These include:
Tell the doctor or laboratory staff that you are taking Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion if you have to provide a blood or urine sample.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or other healthcare professional for advice before receiving this medicine. Your doctor will decide if Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is right for you.
Piperacillin and tazobactam can pass to a baby in the womb or through breast milk. If you are breast-feeding, your doctor will decide if Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is right for you.
The use of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion is not expected to affect the ability to drive or use machines.
This medicinal product contains 217 mg (9.44 mmol) sodium per vial, equivalent to 10.8% of the WHO recommended maximum daily intake of 2g sodium for an adult.
Your doctor or other healthcare professional will give you this medicine through an infusion (a drip for 30 minutes) into one of your veins.
Adults and adolescents above 12 years old
The usual dose is 4 g/0.5 g piperacillin/tazobactam given every 6-8 hours, which is given into one of your veins (directly into the blood stream)
Children aged 2 to 12 years
The usual dose for children with abdominal infections is 100 mg / 12.5 mg / kg of body weight of piperacillin / tazobactam given every 8 hours into one of your veins (directly into the blood stream). The usual dose for children with low white blood cell counts is 80 mg / 10 mg / kg of body weight of piperacillin / tazobactam given every 6 hours into one of your veins (directly into the blood stream).
Your doctor will calculate the dose depending on your child’s weight but each individual dose will not exceed 4 g / 0.5 g of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion.
You will be given Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion until the sign of infection has gone completely (5 to 14 days).
Patients with kidney problems
Your doctor may need to reduce the dose of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion or how often you are given it. Your doctor may also want to test your blood to make sure that your treatment is at the right dose, especially if you have to take this medicine for a long time.
As you will receive Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion from a doctor or other healthcare professional, you are unlikely to be given the wrong dose. However, if you experience side effects, such as convulsions, or think you have been given too much, tell your doctor immediately.
If you think you have not been given a dose of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion, tell your doctor or other healthcare professional immediately.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
See a doctor immediately if you experience any of these potentially serious side effects of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion:
The serious side effects (with frequency in brackets) of Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion are:
If any of the following side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or other healthcare professional.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Not known side effects (frequency cannot be estimated from the available data):
Piperacillin therapy has been associated with an increased incidence of fever and rash in cystic fibrosis patients.
Beta-lactam antibiotics, including piperacillin tazobactam, may lead to signs of altered brain function (encephalopathy) and convulsions.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and vial after “EXP”. The expiry date refers to the last day of that month.
Unopened vials: This medicinal product does not require any special storage conditions.
For single use only. Discard any unused solution.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion comes in packs containing one small bottle of powder which must be dissolved into a solution before it is given to you by infusion (a slow ‘drip’) into your vein.
Packs containing 1 vial; 10 vials (clinical package); 50 vials (clinical package); 100 vials (clinical package).
Not all pack sizes may be marketed.
Marketing authorisation holder
Manufacturer
This medicinal product is authorized in the Member States of the EEA under the following names:
Denmark Piperacillin/Tazobactam Reig Jofre
Finland Piperacillin/Tazobactam Reig Jofre
France PIPERACILLINE / TAZOBACTAM REIG JOFRE 4 g/0,5 g, poudre pour solution pour perfusion
Italy Piperacillina/Tazobactam Reig Jofre
Norway Piperacillin/Tazobactam Reig Jofre
Poland Piperacylina + Tazobaktam Reig Jofre
Sweden Piperacillin/Tazobactam Reig Jofre
United Kingdom Piperacillin/Tazobactam
This leaflet was last revised in 10/2025.